Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Solutions for the temperature-induced challenges for Integrated Circuits

Author: Mansour KhatibAn Electro-Thermal aware design environment system is the best solution for detecting thermal flaws and weaknesses to ensure reliable, high-performance integrated circuits....

An untapped value play in chrome and PGM

As commodity prices continue to soar due to COVID-induced supply shortages, the Russia-Ukraine war and record inflation, metals producers are occupying an enviable position in the global investmen...

The Fed Induced Twilight-Zone

The past three weeks have been filled with intense drama, incredible highs and lows, political battles that continue to this day, and millions of questions from people throughout the world. Throughout this COVID-19 virus event and the collapse of the US and global markets, o...

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. Clinical-stage biopharmaceutical company Fate Thera...

Where Next After the Daily S&P 500 Consolidation?

With yesterday's hefty gains taken off the table, and a new profitable position that has them secured already, will the S&P 500 let me add to the tally some more still today? Given yesterday's Powell-testimony-induced wild swings and preceding strong retail sales data, it's no...

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...

Sask. Project Sees Outstanding Mineralization in Time for the Zinc Boom

IWA Highlights SKRR Watts Lake Zinc Project Zinc prices have climbed ~8% over the past week to over $4,420/t, excluding the panic-induced spike to nearly $4,900/t on March 8, this represents the highest level in 16 years. Fears of impending supply shortages and potentia...

dynaCERT, McPhy, SolGold - the right shares for the future

Scalability is usually a key feature for success stories. As soon as the preliminary work or development is completed, the money-making process begins. Patents can also be equivalent to a license to print money. In addition to the technology industry, the description also appl...

Geologica Resource Corp. advancing B.C. copper-gold property

Geologica Resource Corp. is engaged in acquiring and exploring mineral properties in North America, developing them into world-class deposits. The Vancouver-based mineral explorer is primarily focused on its Topley Property in Central British Columbia. The Market ...

Apple (NASDAQ: AAPL): When to buy the world's hottest stock

Shares of Apple Inc. ( NASDAQ: AAPL , Stock Forum ) are taking a breather, leaving many investors wondering if they've made an iBoo-Boo. The hottest stock on the Nasdaq has fallen more than 4.6% as I write this since hitting a new intraday high of $526.29 on February 15...
1 2 3 4 5 6 7